For their part, Union and state governments have time and again voiced their concern. The Centre wants to make manufacture and marketing of spurious drugs a cognisable offence under the Indian Penal Code. It has plans to make the post-marketing surveillance system for drugs more efficient. States, too, have vowed to become more pro-active. A Pharmaceutical Research and Development Committee, set up in 1999 and headed by R A Mashelkar, has recommended measures to strengthen the regulatory set-up in the country. Now, another expert committee headed by Dr Mashelkar has been directed to give recommendations on the same within six months. The establishment now needs to walk the talk. Law enforcement even within the existing legislation has to become more effective. Industry, too, must take up cudgels on its own behalf. For instance, it can help plug the existing vacuum in the enforcement process by sending out trained investigators who could work in tandem with under-staffed governmental agencies. And they can voluntarily adopt innovative packaging. Finally, given that consumers of spurious drugs tend to be poor and illiterate, a public awareness campaign should be kicked off simultaneously. After all, if the government can encourage a shakeout for drug suppliers to India, there is no reason why it should dither over a similar shakeout within this country.